vs
Bath & Body Works, Inc.（BBWI）与直觉外科（ISRG）财务数据对比。点击上方公司名可切换其他公司
直觉外科的季度营收约是Bath & Body Works, Inc.的1.7倍（$2.8B vs $1.6B），直觉外科净利率更高（29.8% vs 4.8%，领先25.0%），直觉外科同比增速更快（23.0% vs -1.0%），过去两年直觉外科的营收复合增速更高（17.4% vs -26.0%）
Bath & Body Works, Inc.是总部位于美国俄亥俄州哥伦布市的特色零售企业，旗下拥有同名身体护理及家居香氛零售品牌Bath & Body Works，2023年营收达74亿美元，在2024年《财富》美国500强榜单中位列第481位。
直觉外科（Intuitive Surgical）是美国医疗科技企业，主打研发、生产及销售微创外科手术机器人产品，核心产品为达芬奇手术系统，可有效提升患者临床治疗效果。该公司为纳斯达克100、标普100及标普500指数成分股，截至2021年末全球达芬奇系统装机量达6730台，其中美国市场占4139台。
BBWI vs ISRG — 直观对比
营收规模更大
ISRG
是对方的1.7倍
$1.6B
营收增速更快
ISRG
高出24.0%
-1.0%
净利率更高
ISRG
高出25.0%
4.8%
两年增速更快
ISRG
近两年复合增速
-26.0%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $2.8B |
| 净利润 | $77.0M | $826.0M |
| 毛利率 | 41.3% | 66.1% |
| 营业利润率 | 10.1% | — |
| 净利率 | 4.8% | 29.8% |
| 营收同比 | -1.0% | 23.0% |
| 净利润同比 | -27.4% | 17.4% |
| 每股收益（稀释后） | $0.37 | $2.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBWIISRG
| Q1 26 | — | $2.8B | ||
| Q4 25 | $1.6B | $2.9B | ||
| Q3 25 | $1.5B | $2.5B | ||
| Q2 25 | $1.4B | $2.4B | ||
| Q1 25 | $2.8B | $2.3B | ||
| Q4 24 | $1.6B | $2.4B | ||
| Q3 24 | $1.5B | $2.0B | ||
| Q2 24 | $1.4B | $2.0B |
净利润BBWIISRG
| Q1 26 | — | $826.0M | ||
| Q4 25 | $77.0M | $794.8M | ||
| Q3 25 | $64.0M | $704.4M | ||
| Q2 25 | $105.0M | $658.4M | ||
| Q1 25 | $453.0M | $698.4M | ||
| Q4 24 | $106.0M | $685.7M | ||
| Q3 24 | $152.0M | $565.1M | ||
| Q2 24 | $87.0M | $526.9M |
毛利率BBWIISRG
| Q1 26 | — | 66.1% | ||
| Q4 25 | 41.3% | 66.4% | ||
| Q3 25 | 41.3% | 66.4% | ||
| Q2 25 | 45.4% | 66.3% | ||
| Q1 25 | 46.7% | 64.7% | ||
| Q4 24 | 43.5% | 68.0% | ||
| Q3 24 | 41.0% | 67.4% | ||
| Q2 24 | 43.8% | 68.3% |
营业利润率BBWIISRG
| Q1 26 | — | — | ||
| Q4 25 | 10.1% | 30.2% | ||
| Q3 25 | 10.1% | 30.3% | ||
| Q2 25 | 14.7% | 30.5% | ||
| Q1 25 | 24.3% | 25.7% | ||
| Q4 24 | 13.5% | 30.4% | ||
| Q3 24 | 12.0% | 28.3% | ||
| Q2 24 | 13.5% | 28.2% |
净利率BBWIISRG
| Q1 26 | — | 29.8% | ||
| Q4 25 | 4.8% | 27.7% | ||
| Q3 25 | 4.1% | 28.1% | ||
| Q2 25 | 7.4% | 27.0% | ||
| Q1 25 | 16.3% | 31.0% | ||
| Q4 24 | 6.6% | 28.4% | ||
| Q3 24 | 10.0% | 27.7% | ||
| Q2 24 | 6.3% | 26.2% |
每股收益（稀释后）BBWIISRG
| Q1 26 | — | $2.28 | ||
| Q4 25 | $0.37 | $2.19 | ||
| Q3 25 | $0.30 | $1.95 | ||
| Q2 25 | $0.49 | $1.81 | ||
| Q1 25 | $2.06 | $1.92 | ||
| Q4 24 | $0.49 | $1.89 | ||
| Q3 24 | $0.68 | $1.56 | ||
| Q2 24 | $0.38 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $236.0M | — |
| 总债务越低越好 | $3.9B | — |
| 股东权益账面价值 | $-1.6B | $17.6B |
| 总资产 | $5.0B | $20.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BBWIISRG
| Q1 26 | — | — | ||
| Q4 25 | $236.0M | $5.9B | ||
| Q3 25 | $364.0M | $4.9B | ||
| Q2 25 | $636.0M | $5.3B | ||
| Q1 25 | $674.0M | $4.5B | ||
| Q4 24 | $191.0M | $4.0B | ||
| Q3 24 | $514.0M | $4.2B | ||
| Q2 24 | $855.0M | $4.8B |
总债务BBWIISRG
| Q1 26 | — | — | ||
| Q4 25 | $3.9B | — | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.2B | — | ||
| Q2 24 | $4.3B | — |
股东权益BBWIISRG
| Q1 26 | — | $17.6B | ||
| Q4 25 | $-1.6B | $17.8B | ||
| Q3 25 | $-1.5B | $16.9B | ||
| Q2 25 | $-1.5B | $17.8B | ||
| Q1 25 | $-1.4B | $17.1B | ||
| Q4 24 | $-1.7B | $16.4B | ||
| Q3 24 | $-1.7B | $15.6B | ||
| Q2 24 | $-1.7B | $14.7B |
总资产BBWIISRG
| Q1 26 | — | $20.1B | ||
| Q4 25 | $5.0B | $20.5B | ||
| Q3 25 | $4.8B | $19.4B | ||
| Q2 25 | $4.9B | $20.2B | ||
| Q1 25 | $4.9B | $19.2B | ||
| Q4 24 | $5.0B | $18.7B | ||
| Q3 24 | $4.9B | $17.7B | ||
| Q2 24 | $5.2B | $16.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $80.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-1.0M | — |
| 自由现金流率自由现金流/营收 | -0.1% | — |
| 资本支出强度资本支出/营收 | 5.1% | — |
| 现金转化率经营现金流/净利润 | 1.04× | — |
| 过去12个月自由现金流最近4个季度 | $946.0M | — |
8季度趋势，按日历期对齐
经营现金流BBWIISRG
| Q1 26 | — | — | ||
| Q4 25 | $80.0M | $892.5M | ||
| Q3 25 | $-43.0M | $841.0M | ||
| Q2 25 | $188.0M | $715.4M | ||
| Q1 25 | $955.0M | $581.6M | ||
| Q4 24 | $-99.0M | $822.6M | ||
| Q3 24 | $-46.0M | $706.5M | ||
| Q2 24 | $76.0M | $620.5M |
自由现金流BBWIISRG
| Q1 26 | — | — | ||
| Q4 25 | $-1.0M | $730.0M | ||
| Q3 25 | $-99.0M | $735.6M | ||
| Q2 25 | $151.0M | $560.1M | ||
| Q1 25 | $895.0M | $465.0M | ||
| Q4 24 | $-164.0M | $510.6M | ||
| Q3 24 | $-101.0M | $458.6M | ||
| Q2 24 | $30.0M | $311.1M |
自由现金流率BBWIISRG
| Q1 26 | — | — | ||
| Q4 25 | -0.1% | 25.5% | ||
| Q3 25 | -6.4% | 29.4% | ||
| Q2 25 | 10.6% | 23.0% | ||
| Q1 25 | 32.1% | 20.6% | ||
| Q4 24 | -10.2% | 21.2% | ||
| Q3 24 | -6.6% | 22.5% | ||
| Q2 24 | 2.2% | 15.5% |
资本支出强度BBWIISRG
| Q1 26 | — | — | ||
| Q4 25 | 5.1% | 5.7% | ||
| Q3 25 | 3.6% | 4.2% | ||
| Q2 25 | 2.6% | 6.4% | ||
| Q1 25 | 2.2% | 5.2% | ||
| Q4 24 | 4.0% | 12.9% | ||
| Q3 24 | 3.6% | 12.2% | ||
| Q2 24 | 3.3% | 15.4% |
现金转化率BBWIISRG
| Q1 26 | — | — | ||
| Q4 25 | 1.04× | 1.12× | ||
| Q3 25 | -0.67× | 1.19× | ||
| Q2 25 | 1.79× | 1.09× | ||
| Q1 25 | 2.11× | 0.83× | ||
| Q4 24 | -0.93× | 1.20× | ||
| Q3 24 | -0.30× | 1.25× | ||
| Q2 24 | 0.87× | 1.18× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBWI
| Bath Body Works Stores | $1.2B | 77% |
| Bath Body Works Direct | $299.0M | 19% |
| Bath Body Works International | $73.0M | 5% |
ISRG
| Instruments and accessories | $1.7B | 61% |
| Systems | $650.7M | 23% |
| Services | $433.7M | 16% |
